Form 4 for TELA TELA Bio, Inc.
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-19 · accession 0001062993-25-003151 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-19 | TELA | Smeykal Megan | CAO, Ctrl | A - Grant | $0.00 | +9,400 | 39.5K | +31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | A | A | 9,400 | $0.00 | 39,479 | D | — | — | (F1) Includes 1,079 shares acquired under the Issuer's employee stock purchase plan on July 31, 2024. (F2) These restricted stock units will vest in four equal annual installments beginning on February 19, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates. |